Personalized medicine is becoming more popular with the growing number of genetic disorders. Also, the increasing awareness about Personalized medicine is driving the market with a high growth rate in the future. The growing technological advancement such as NGS and molecular services are augmenting the demand for gene expression services. Additionally, development of genomic databases, increased government funding towards genomics, and growth in personalized medicine are likely to drive the market. However, factors such as, Lack of Skilled Labor and high cost of instruments will lead to the decline of the market in the forecast period.

Key Market Trends

Next Generation Sequencing (NGS) is expected to grow with a healthy CAGR

NGS is a technology in which millions of DNA strands can be sequenced through massive parallelization; this technique is also known as high throughput sequencing. The low cost, high accuracy and speed, and precise results even from low sample input are the main advantages NGS offers over Sanger’s sequencing method. NGS is, therefore, being used to execute various applications, such as biomarker discovery, oncology studies, personalized medicine, and agricultural and animal research, among others. After the introduction of NGS technologies in 2005, they have had an incredible influence on genomic research. Next-generation sequencing, currently, has its application in the diagnosis of a variety of illnesses, such as cancer, hematological disorders, neurology, psychiatry, dysmorphology, vision and hearing impairment, cardiology, and pharmacogenomics. It is also used as a tool for noninvasive prenatal tests. NGS technology can be used for large-scale screening of SNPs, to ultimately determine if a drug candidate will be effective and safe. NGS can help change DNA sequencing and genetic characterization used in drug discovery and drug development.

North America Lead the Global Gene Expression Analysis Market

Owing to the increased funding and support activities by the government and non-government entities North America is dominating the Global Gene Expression Analysis Market. By supporting genomics research, various government bodies, like NHGRI (National Human Genome Research Institute), have supported the work on sequencing of the human genome, and fund research on the genome’s structure, function, and role in health and disease. They also support studies on the ethical, legal, and social implications (ELSI) of genome research. The US National Human Genome Research Institute and the US National Academy of Medicine organized 90 leaders in genomic medicine from the United States and 25 other countries in Genomic Medicine Symposium in 2014, in order to identify opportunities for collaborations that promote the responsible practice of genomic medicine.

Competitive Landscape

The Gene Expression Analysis market is highly fragmented with the presence of a large number of local and international players. Key players are adopting different growth strategies to enhance their market presence such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. The Major Players in the market includes Arthrex Inc., Depuy Synthes, DJO Surgical, Integra Lifesciences, Smith & Nephew, Stryker Corporation, Wright Medical Group, and Zimmer Holdings Inc., among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client’s requirements
  • 3 months of analyst support